The external ventricular drain market size has grown strongly in recent years. It will grow from $4.99 billion in 2025 to $5.33 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing incidence of traumatic brain injury, rising cases of intracranial hemorrhage, growing prevalence of hydrocephalus, expansion of neurosurgical care facilities, increased adoption of critical care monitoring practices.
The external ventricular drain market size is expected to see strong growth in the next few years. It will grow to $6.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising burden of neurological disorders, growing demand for advanced neurocritical care, increasing investments in neurosurgery infrastructure, rising awareness of intracranial pressure management, expanding access to specialty neurological hospitals. Major trends in the forecast period include rising use of external ventricular drains in neurocritical care, growing adoption of adjustable and continuous evd systems, increasing demand for accurate intracranial pressure management, rising focus on infection control in cerebrospinal fluid drainage, growing utilization of evds in traumatic brain injury management.
The rising incidence of traumatic brain injuries (TBI) is anticipated to drive the expansion of the external ventricular drain market in the future. Traumatic brain injury (TBI) refers to damage to the brain caused by external force, which can lead to temporary or permanent impairment of cognitive, physical, and psychosocial functions. The increasing occurrence of traumatic brain injuries can be attributed to factors such as increased participation in contact sports, higher rates of motor vehicle accidents, and an aging population prone to falls. TBIs can cause elevated intracranial pressure (ICP) due to swelling, hemorrhage, or the accumulation of cerebrospinal fluid (CSF), all of which can result in further brain damage. External ventricular drains (EVDs) help mitigate these effects by draining excess CSF and continuously monitoring ICP. For instance, in October 2023, according to the World Federation of Neurology, a UK-based organization dedicated to advancing neurological practice and research globally, over 40% of the world’s population is affected by a neurological condition, with this number expected to nearly double by 2050. Therefore, the growing incidence of traumatic brain injuries is fueling the expansion of the external ventricular drain market.
Major companies operating in the external ventricular drain market are focusing on developing innovative solutions such as neurocritical care devices to improve patient outcomes, enhance procedural efficiency, and manage complex neurological conditions. Neurocritical care devices are medical tools used to monitor and treat critically ill patients with severe neurological disorders, supporting functions such as intracranial pressure monitoring and cerebrospinal fluid drainage. For instance, in March 2025, Anuncia Medical Inc., a US-based neurotherapeutic device company, received FDA Breakthrough Device Designation for its ReFlow External Ventricular Drains (EVD), a novel device designed to control brain swelling and elevated intracranial pressure. The ReFlow EVD is the first device to feature a noninvasive, manual flushing mechanism to restore and maintain cerebrospinal fluid (CSF) flow. It can be operated by nurses during routine checks, potentially reducing ICU stays, additional surgeries, and costly EVD replacements. This designation broadens Anuncia's portfolio beyond hydrocephalus management into acute neurocritical care, improving patient outcomes and clinical workflows.
In June 2023, Luciole Medical AG, a medical technology company headquartered in Switzerland, acquired Spiegelberg GmbH & Co. KG for an undisclosed sum. This acquisition will see the integration of their product ranges, manufacturing capacities, and distribution channels, harnessing their respective strengths with the goal of emerging as leaders in the development of next-generation brain monitoring devices. Spiegelberg GmbH & Co. KG is a German company known for its provision of catheters and external ventricular drainage kits.
Major companies operating in the external ventricular drain market are Medtronic Plc, B. Braun SE, Integra LifeSciences, Teleflex Incorporated, Spiegelberg GmbH & Co. KG, IRRAS AB, Sophysa, Raumedic AG, Luciole Medical AG, Fuji Systems Corporation, Ad-Tech Medical Instrument Corporation, Mizuho Medical Co. Ltd., Nipro Corporation, Kaneka Corporation, Samyang Biopharmaceuticals Corporation, Neuromedex GmbH, SILMAG S.A., Tokibo Co. Ltd., Well Lead Medical Co. Ltd., Beijing Xinlingwei Technology Co. Ltd.
North America was the largest region in the external ventricular drain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external ventricular drain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the external ventricular drain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the external ventricular drain market by increasing the cost of imported catheters, pressure monitoring components, and sterile drainage accessories. These effects are most visible in hospitals and specialty hospitals across regions dependent on global medical device supply chains, particularly asia-pacific and europe. Higher procurement costs have influenced purchasing decisions for complete drainage sets and accessories. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and cost-optimized EVD system designs, strengthening long-term supply resilience.
The external ventricular drain market research report is one of a series of new reports that provides external ventricular drain market statistics, including external ventricular drain industry global market size, regional shares, competitors with a external ventricular drain market share, detailed external ventricular drain market segments, market trends and opportunities, and any further data you may need to thrive in the external ventricular drain industry. This external ventricular drain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An external ventricular drain (EVD) is a medical device used to relieve elevated intracranial pressure (ICP) by draining cerebrospinal fluid (CSF) from the brain's ventricles to an external collection system. This helps prevent damage to brain tissues and alleviates symptoms such as headaches, nausea, and altered consciousness. The procedure is commonly used for patients with various disorders that cause an accumulation of excess CSF within the cranial cavity.
External ventricular drains come in two main types, external ventricular drainage sets and accessories. An external ventricular drainage set is a medical device employed to alleviate heightened intracranial pressure by redirecting cerebrospinal fluid from the brain's ventricles to an external collection system. Its applications span across various conditions such as traumatic brain injury, intracranial hemorrhage, hydrocephalus, and others. These devices are utilized by a range of end users including hospitals, specialty hospitals, specialty clinics, and others.
The external ventricular drain market consists of sales of drainage systems, catheters, valve mechanisms, ICP monitors and transducers, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The external ventricular drain market size is expected to see strong growth in the next few years. It will grow to $6.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising burden of neurological disorders, growing demand for advanced neurocritical care, increasing investments in neurosurgery infrastructure, rising awareness of intracranial pressure management, expanding access to specialty neurological hospitals. Major trends in the forecast period include rising use of external ventricular drains in neurocritical care, growing adoption of adjustable and continuous evd systems, increasing demand for accurate intracranial pressure management, rising focus on infection control in cerebrospinal fluid drainage, growing utilization of evds in traumatic brain injury management.
The rising incidence of traumatic brain injuries (TBI) is anticipated to drive the expansion of the external ventricular drain market in the future. Traumatic brain injury (TBI) refers to damage to the brain caused by external force, which can lead to temporary or permanent impairment of cognitive, physical, and psychosocial functions. The increasing occurrence of traumatic brain injuries can be attributed to factors such as increased participation in contact sports, higher rates of motor vehicle accidents, and an aging population prone to falls. TBIs can cause elevated intracranial pressure (ICP) due to swelling, hemorrhage, or the accumulation of cerebrospinal fluid (CSF), all of which can result in further brain damage. External ventricular drains (EVDs) help mitigate these effects by draining excess CSF and continuously monitoring ICP. For instance, in October 2023, according to the World Federation of Neurology, a UK-based organization dedicated to advancing neurological practice and research globally, over 40% of the world’s population is affected by a neurological condition, with this number expected to nearly double by 2050. Therefore, the growing incidence of traumatic brain injuries is fueling the expansion of the external ventricular drain market.
Major companies operating in the external ventricular drain market are focusing on developing innovative solutions such as neurocritical care devices to improve patient outcomes, enhance procedural efficiency, and manage complex neurological conditions. Neurocritical care devices are medical tools used to monitor and treat critically ill patients with severe neurological disorders, supporting functions such as intracranial pressure monitoring and cerebrospinal fluid drainage. For instance, in March 2025, Anuncia Medical Inc., a US-based neurotherapeutic device company, received FDA Breakthrough Device Designation for its ReFlow External Ventricular Drains (EVD), a novel device designed to control brain swelling and elevated intracranial pressure. The ReFlow EVD is the first device to feature a noninvasive, manual flushing mechanism to restore and maintain cerebrospinal fluid (CSF) flow. It can be operated by nurses during routine checks, potentially reducing ICU stays, additional surgeries, and costly EVD replacements. This designation broadens Anuncia's portfolio beyond hydrocephalus management into acute neurocritical care, improving patient outcomes and clinical workflows.
In June 2023, Luciole Medical AG, a medical technology company headquartered in Switzerland, acquired Spiegelberg GmbH & Co. KG for an undisclosed sum. This acquisition will see the integration of their product ranges, manufacturing capacities, and distribution channels, harnessing their respective strengths with the goal of emerging as leaders in the development of next-generation brain monitoring devices. Spiegelberg GmbH & Co. KG is a German company known for its provision of catheters and external ventricular drainage kits.
Major companies operating in the external ventricular drain market are Medtronic Plc, B. Braun SE, Integra LifeSciences, Teleflex Incorporated, Spiegelberg GmbH & Co. KG, IRRAS AB, Sophysa, Raumedic AG, Luciole Medical AG, Fuji Systems Corporation, Ad-Tech Medical Instrument Corporation, Mizuho Medical Co. Ltd., Nipro Corporation, Kaneka Corporation, Samyang Biopharmaceuticals Corporation, Neuromedex GmbH, SILMAG S.A., Tokibo Co. Ltd., Well Lead Medical Co. Ltd., Beijing Xinlingwei Technology Co. Ltd.
North America was the largest region in the external ventricular drain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external ventricular drain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the external ventricular drain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the external ventricular drain market by increasing the cost of imported catheters, pressure monitoring components, and sterile drainage accessories. These effects are most visible in hospitals and specialty hospitals across regions dependent on global medical device supply chains, particularly asia-pacific and europe. Higher procurement costs have influenced purchasing decisions for complete drainage sets and accessories. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and cost-optimized EVD system designs, strengthening long-term supply resilience.
The external ventricular drain market research report is one of a series of new reports that provides external ventricular drain market statistics, including external ventricular drain industry global market size, regional shares, competitors with a external ventricular drain market share, detailed external ventricular drain market segments, market trends and opportunities, and any further data you may need to thrive in the external ventricular drain industry. This external ventricular drain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An external ventricular drain (EVD) is a medical device used to relieve elevated intracranial pressure (ICP) by draining cerebrospinal fluid (CSF) from the brain's ventricles to an external collection system. This helps prevent damage to brain tissues and alleviates symptoms such as headaches, nausea, and altered consciousness. The procedure is commonly used for patients with various disorders that cause an accumulation of excess CSF within the cranial cavity.
External ventricular drains come in two main types, external ventricular drainage sets and accessories. An external ventricular drainage set is a medical device employed to alleviate heightened intracranial pressure by redirecting cerebrospinal fluid from the brain's ventricles to an external collection system. Its applications span across various conditions such as traumatic brain injury, intracranial hemorrhage, hydrocephalus, and others. These devices are utilized by a range of end users including hospitals, specialty hospitals, specialty clinics, and others.
The external ventricular drain market consists of sales of drainage systems, catheters, valve mechanisms, ICP monitors and transducers, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. External Ventricular Drain Market Characteristics
3. External Ventricular Drain Market Supply Chain Analysis
4. Global External Ventricular Drain Market Trends and Strategies
5. External Ventricular Drain Market Analysis of End Use Industries
7. Global External Ventricular Drain Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global External Ventricular Drain Total Addressable Market (TAM) Analysis for the Market
9. External Ventricular Drain Market Segmentation
10. External Ventricular Drain Market Regional and Country Analysis
11. Asia-Pacific External Ventricular Drain Market
12. China External Ventricular Drain Market
13. India External Ventricular Drain Market
14. Japan External Ventricular Drain Market
15. Australia External Ventricular Drain Market
16. Indonesia External Ventricular Drain Market
17. South Korea External Ventricular Drain Market
18. Taiwan External Ventricular Drain Market
19. South East Asia External Ventricular Drain Market
20. Western Europe External Ventricular Drain Market
21. UK External Ventricular Drain Market
22. Germany External Ventricular Drain Market
23. France External Ventricular Drain Market
24. Italy External Ventricular Drain Market
25. Spain External Ventricular Drain Market
26. Eastern Europe External Ventricular Drain Market
27. Russia External Ventricular Drain Market
28. North America External Ventricular Drain Market
29. USA External Ventricular Drain Market
30. Canada External Ventricular Drain Market
31. South America External Ventricular Drain Market
32. Brazil External Ventricular Drain Market
33. Middle East External Ventricular Drain Market
34. Africa External Ventricular Drain Market
36. External Ventricular Drain Market Competitive Landscape and Company Profiles
37. External Ventricular Drain Market Other Major and Innovative Companies
40. External Ventricular Drain Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
External Ventricular Drain Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses external ventricular drain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for external ventricular drain? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The external ventricular drain market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: External Ventricular Drainage Set; Accessories2) By Application: Traumatic Brain Injury; Intracranial Hemorrhage; Hydrocephalus; Other Applications
3) By End-User: Hospitals; Specialty Hospitals; Specialty Clinics; Other End-Users
Subsegments:
1) By External Ventricular Drainage Set: Standard External Ventricular Drainage Set; Adjustable External Ventricular Drainage Set; Continuous External Ventricular Drainage Set2) By Accessories: Catheters; Pressure Monitoring Devices; Drainage Bags; Connecting Tubes
Companies Mentioned: Medtronic Plc; B. Braun SE; Integra LifeSciences; Teleflex Incorporated; Spiegelberg GmbH & Co. KG; IRRAS AB; Sophysa; Raumedic AG; Luciole Medical AG; Fuji Systems Corporation; Ad-Tech Medical Instrument Corporation; Mizuho Medical Co. Ltd.; Nipro Corporation; Kaneka Corporation; Samyang Biopharmaceuticals Corporation; Neuromedex GmbH; SILMAG S.A.; Tokibo Co. Ltd.; Well Lead Medical Co. Ltd.; Beijing Xinlingwei Technology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this External Ventricular Drain market report include:- Medtronic Plc
- B. Braun SE
- Integra LifeSciences
- Teleflex Incorporated
- Spiegelberg GmbH & Co. KG
- IRRAS AB
- Sophysa
- Raumedic AG
- Luciole Medical AG
- Fuji Systems Corporation
- Ad-Tech Medical Instrument Corporation
- Mizuho Medical Co. Ltd.
- Nipro Corporation
- Kaneka Corporation
- Samyang Biopharmaceuticals Corporation
- Neuromedex GmbH
- SILMAG S.A.
- Tokibo Co. Ltd.
- Well Lead Medical Co. Ltd.
- Beijing Xinlingwei Technology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.33 Billion |
| Forecasted Market Value ( USD | $ 6.74 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
